Skip to content
BACK to News

MyTumorID: ID Your Tumor. ID Your Options.

Published on February 18, 2025 in MyTumorID

A brain tumor diagnosis can feel overwhelming, but knowledge is key to making informed decisions about care. Biomarker testing helps uncover critical details about a tumor’s genetic makeup, which can open doors to targeted treatments and clinical trials.

In this video, brain tumor community members and experts explain why understanding your tumor through biomarker testing is essential and how clinical trials can provide access to innovative therapies. National Brain Tumor Society’s MyTumorID campaign empowers patients with brain tumors and their caregivers with the information they need about biomarker testing and clinical trials to make informed decisions about their care.

ID Your Tumor. ID Your Options.

The most recent WHO Classification of Tumours emphasizes the importance of biomarker testing in the diagnosis of brain tumors, yet nearly 70% of patients with brain tumors reported not understanding what biomarker testing is in a recent survey.

Through the MyTumorID campaign, the National Brain Tumor Society is committed to educating patients and their care partners about the value of biomarker testing and clinical trials, empowering patients to identify their tumor, understand their options, and make informed decisions about their treatment. 

Learn More

See All News


Stay Informed & Connected